title: Does CMT1A homozygosity cause more severe disease with root hypertrophy and higher CSF proteins?
authors.affiliation: Division of Neurology, Carlo Besta National Neurological Institute, Milan, Italy. dpareys@tin.it
authors.forename: D
authors.initials: D
authors.lastname: Pareyson
authors.forename: D
authors.initials: D
authors.lastname: Testa
authors.forename: M
authors.initials: M
authors.lastname: Morbin
authors.forename: A
authors.initials: A
authors.lastname: Erbetta
authors.forename: C
authors.initials: C
authors.lastname: Ciano
authors.forename: G
authors.initials: G
authors.lastname: Lauria
authors.forename: M
authors.initials: M
authors.lastname: Milani
authors.forename: F
authors.initials: F
authors.lastname: Taroni
mesh_terms: D002420:Cauda Equina / Q000473:pathology*; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis*; D002607:Charcot-Marie-Tooth Disease / Q000134:cerebrospinal fluid / Q000235:genetics* / Q000473:pathology; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D003241:Consanguinity; D018450:Disease Progression; D018628:Gene Dosage; D020440:Gene Duplication; D006720:Homozygote; D006801:Humans; D006984:Hypertrophy; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009185:Myelin Proteins / Q000235:genetics*; D013497:Sural Nerve / Q000473:pathology
chemical_list: D002556:Cerebrospinal Fluid Proteins; D009185:Myelin Proteins; C073687:PMP22 protein, human